CY1119418T1 - Συνθεσεις για επηρεασμο απωλειας βαρους που περιλαμβανουν ανταγωνιστη οπιοειδους και μπουπροπιονη - Google Patents
Συνθεσεις για επηρεασμο απωλειας βαρους που περιλαμβανουν ανταγωνιστη οπιοειδους και μπουπροπιονηInfo
- Publication number
- CY1119418T1 CY1119418T1 CY20171100932T CY171100932T CY1119418T1 CY 1119418 T1 CY1119418 T1 CY 1119418T1 CY 20171100932 T CY20171100932 T CY 20171100932T CY 171100932 T CY171100932 T CY 171100932T CY 1119418 T1 CY1119418 T1 CY 1119418T1
- Authority
- CY
- Cyprus
- Prior art keywords
- weight loss
- compound
- compositions
- bupropionion
- including optional
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 230000004580 weight loss Effects 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 108010008364 Melanocortins Proteins 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 239000002865 melanocortin Substances 0.000 abstract 2
- 102000003840 Opioid Receptors Human genes 0.000 abstract 1
- 108090000137 Opioid Receptors Proteins 0.000 abstract 1
- 235000019789 appetite Nutrition 0.000 abstract 1
- 230000036528 appetite Effects 0.000 abstract 1
- 239000003401 opiate antagonist Substances 0.000 abstract 1
- 230000004962 physiological condition Effects 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 230000036186 satiety Effects 0.000 abstract 1
- 235000019627 satiety Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46683803P | 2003-04-29 | 2003-04-29 | |
EP07116330A EP1870096A3 (en) | 2003-04-29 | 2004-04-21 | Compositions for affecting weight loss |
EP04760321A EP1617832B1 (en) | 2003-04-29 | 2004-04-21 | Compositions for affecting weight loss |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1119418T1 true CY1119418T1 (el) | 2018-03-07 |
Family
ID=38719840
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20171100932T CY1119418T1 (el) | 2003-04-29 | 2017-09-05 | Συνθεσεις για επηρεασμο απωλειας βαρους που περιλαμβανουν ανταγωνιστη οπιοειδους και μπουπροπιονη |
CY2017041C CY2017041I1 (el) | 2003-04-29 | 2017-12-11 | Συνθεσεις για επηρεασμο απωλειας βαρους που περιλαμβανουν ανταγωνιστη οπιοειδους και μπουπροπιονη |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY2017041C CY2017041I1 (el) | 2003-04-29 | 2017-12-11 | Συνθεσεις για επηρεασμο απωλειας βαρους που περιλαμβανουν ανταγωνιστη οπιοειδους και μπουπροπιονη |
Country Status (6)
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012111011A2 (en) | 2011-02-16 | 2012-08-23 | Nir Barak | Low dosage combinations of fluoxetine and reboxetine for treating obesity |
EP2950799B1 (en) | 2013-01-30 | 2019-12-04 | Pharmorx Therapeutics, Inc. | Treatments for depression and other diseases with a low dose agent |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4217353A (en) * | 1978-05-19 | 1980-08-12 | E. I. Du Pont De Nemours And Company | Method for inducing anorexia |
AU3419995A (en) * | 1994-09-19 | 1996-04-09 | Du Pont Merck Pharmaceutical Company, The | Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence |
ES2393303T3 (es) * | 1996-05-07 | 2012-12-20 | Veroscience Llc | Uso médico y composición para el tratamiento de trastornos del metabolismo de lípidos y de glucosa |
WO1999038504A1 (en) * | 1998-01-29 | 1999-08-05 | Sepracor Inc. | Pharmaceutical uses of optically pure (-)-bupropion |
US6071918A (en) * | 1999-07-21 | 2000-06-06 | Dupont Pharmaceuticals Company | Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence |
US6403657B1 (en) * | 1999-10-04 | 2002-06-11 | Martin C. Hinz | Comprehensive pharmacologic therapy for treatment of obesity |
WO2001052851A1 (en) * | 2000-01-22 | 2001-07-26 | Albert Shulman | Methods for the treatment of substance abuse |
US6770620B2 (en) * | 2000-09-18 | 2004-08-03 | Sanos Bioscience A/S | Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders |
US20030087896A1 (en) * | 2001-08-09 | 2003-05-08 | Hillel Glover | Treatment of refractory depression with an opiate antagonist and an antidepressant |
US20040102440A1 (en) * | 2002-07-01 | 2004-05-27 | Wong Erik Ho Fong | Method of promoting smoking cessation |
JP2005531557A (ja) * | 2002-05-17 | 2005-10-20 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | 選択的オピエート受容体モジュレーターとして効果的な化合物の使用 |
US6972291B2 (en) * | 2002-07-02 | 2005-12-06 | Bernstein Richard K | Method for reducing food intake |
-
2004
- 2004-04-21 EP EP07116330A patent/EP1870096A3/en not_active Withdrawn
-
2017
- 2017-09-05 CY CY20171100932T patent/CY1119418T1/el unknown
- 2017-12-08 FR FR17C1058C patent/FR17C1058I2/fr active Active
- 2017-12-11 CY CY2017041C patent/CY2017041I1/el unknown
- 2017-12-11 NL NL300918C patent/NL300918I2/nl unknown
- 2017-12-11 LU LU00054C patent/LUC00054I2/en unknown
- 2017-12-12 BE BE2017C064C patent/BE2017C064I2/fr unknown
Also Published As
Publication number | Publication date |
---|---|
NL300918I1 (nl) | 2017-12-14 |
FR17C1058I2 (fr) | 2019-01-11 |
CY2017041I2 (el) | 2018-09-05 |
EP1870096A2 (en) | 2007-12-26 |
CY2017041I1 (el) | 2018-09-05 |
LUC00054I1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2017-12-13 |
BE2017C064I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2023-08-09 |
NL300918I2 (nl) | 2018-01-09 |
FR17C1058I1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2018-01-12 |
LUC00054I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2018-02-21 |
EP1870096A3 (en) | 2011-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE388698T1 (de) | Zusammensetzungen zur beeinflussung des gewichtsverlusts | |
TW200605866A (en) | Combination of bupropion and a second compound for affecting weight loss | |
ATE496893T1 (de) | Isochinolinonderivate und deren verwendung als medikamente | |
CY1106600T1 (el) | Ανθεκτικη, στη φθορα συνεξωθημενη μορφη δοσολογιας που περιεχει εναν ενεργο παραγοντα και εναν ανταγωνιστικο παραγοντα και διαδικασια παρασκευης αυτης | |
CY1109310T1 (el) | Φαρμακοτεχνικες μορφες αγωνιστη οποιουχου με απελευθερωσιμο και απομονωμενο ανταγωνιστη | |
CY1114011T1 (el) | Φαρμακευτικη στοματικη δοσολογικη μορφη που περιλαμβανει ενα συνδυασμο ενος οπιοειδους αγωνιστη και ενος οπιοειδους ανταγωνιστη | |
NO20074441L (no) | 1-benzylindol-2-karboksamidderivater | |
CY1113413T1 (el) | Συνθεση και αντι-ιικη δραστηριοτητα των υποκατεστημενων παραγωγων αζαϊνδολοοξοοξικης πιπεραζινης | |
TR200002616T2 (tr) | Simetrik ve simetrik olmayan sübstitüe edilmiş difenil üreler kullanılarak raf kinazın inhibe edilmesi | |
EE200200118A (et) | Terapeutilised kinasoliini derivaadid, nende valmistamise meetod ning kasutamine | |
CY1114133T1 (el) | ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ γ-ΦΑΙΝΥΛ-Δ-ΛΑΚΤΑΜΕΣ ΚΑΙ ΧΡΗΣΕΙΣ ΠΟΥ ΣΧΕΤΙΖΟΝΤΑΙ ΠΡΟΣ ΑΥΤΕΣ | |
CY1110669T1 (el) | Χρησιμοποιηση βενζο-συγχωνευμενων ετεροκυκλικων παραγωγων σουλφαμιδιου για τη θεραπευτικη αγωγη της καταθλιψης | |
CY1119418T1 (el) | Συνθεσεις για επηρεασμο απωλειας βαρους που περιλαμβανουν ανταγωνιστη οπιοειδους και μπουπροπιονη | |
EA200401584A1 (ru) | Способ содействия прекращению курения | |
ATE250045T1 (de) | Indeno-dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel | |
EA200200742A1 (ru) | 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии | |
EP1605847A4 (en) | Antibody-targeted photodynamic therapy | |
EE200200471A (et) | Farmatseutiline kompositsioon, mis sisaldab kamptotetsiini või selle derivaati kombinatsioonis pürimidiini derivaadiga ning on ette nähtud vähktõve raviks | |
CY1106409T1 (el) | Παραγωγα κινολινης | |
ATE312828T1 (de) | Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung | |
DE60027905D1 (de) | Glycokonjugate, glycoaminosäure, deren zwischenprodukte, und ihre verwendung | |
ES2181787T3 (es) | Derivados de la 3h-2,3-benzodiazepina sustituidos en posicion 3, y su su utilizacion como medicamentos | |
BRPI0409505A (pt) | compostos como antagonistas do receptor crf1 | |
DE60011801D1 (de) | Benzoxa- und benzthiazolylsulfamate sowie ihre verwendung als steroid-sulfataseinhibitoren | |
ATE370134T1 (de) | 1,4-dithiin und 1,4-dithiepin-1,1,4,4, tetroxid derivate verwendbar als human galanin receptor antagonisten |